Moderna’s Chief Medical Officer Tal Zaks said the company should be able to supply booster shots by the end of 2021, adding that testing shows the boosters provide a confident level of protection against coronavirus variants.
The National Institutes of Health began testing a booster shot from Moderna against a variant first found in South Africa that has given scientists some cause for concern compared with other strains.
The variant, B.1.351, appears to be more contagious than previous strains and could possibly evade some of the protections generated by therapeutics and vaccines, although preliminary evidence has shown current vaccines provide an adequate degree of protection against variants.
Support Our Work
Your gift to DOJLife.com helps us continue our effort to unite the Dallas Orthodox Jewish community by publishing community news, original, stimulating and inspirational content, organization listings, community Classes & Events calendar, Tefilla calendar, classifieds, gemachs, etc., one site designed with everyone in mind. Donations on this page will be charged in $US and will receive a US tax-receipt.